A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

Blood

Volumn 98, Issue 4, 2001, Pages 1166-1173

  Wulf, Gerald G ^a,b   Wang, Rui Yu ^a,b   Kuehnle, Ingrid ^a,b   Weidner, Douglas ^a,b   Marini, Frank ^a,b   Brenner, Malcolm K ^a,b   Andreeff, Michael ^a,b   Goodell, Margaret A ^a,b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOSTATIC AGENT; DAUNORUBICIN; HOE 33342; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CHILD; CONTROLLED STUDY; DRUG TRANSPORT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GENETIC MARKER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA REMISSION; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RELAPSE; SCID MOUSE; STEM CELL;

EID: 0035883060     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.4.1166     Document Type: Article

References (28)

1. Fialkow PJ, Singer JW, Adamson JW, et al. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood. 1981;57:1068-1073.
2. Keinanen M, Griffin JD, Bloomfield CD, Machnicki J, de la Chapelle A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. N Engl J Med. 1988;318:1153-1158.
3. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730-737.
4. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645-648.
5. Blair A, Hogge DE, Sutherland HJ. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71 (-)/HLA-DR. Blood. 1998;92:4325-4335.
6. Wittebol S, Raymakers R, van de Locht L, Mensink E, de Witte T. In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fraction. Leukemia. 1998;12:1782-1788.
7. Terpstra W, Ploemacher RE, Prins A, et al. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood. 1996;88:1944-1950.
8. Terpstra W, Prins A, Ploemacher RE, et al. Longterm leukemia-initiating capacity of a CD34-sub-population of acute myeloid leukemia. Blood. 1996;87:2187-2194.
9. Zanjani ED, Almeida-Porada G, Livingston AG, Porada CD, Ogawa M. Engraftment and multilineage expression of human bone marrow CD34-cells in vivo. Ann N Y Acad Sci. 1999;872:220-231.
10. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797-1806.
11. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038-1045.
12. Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectabte levels of CD34 antigen exist in multiple species. Nat Med. 1997;3:1337-1345.
13. Engel H, Goodacre A, Keyhani A, et al. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission. Br J Haematol. 1997;99:64-75.
14. Engel H, Drach J, Keyhani A, et al. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells. Leukemia. 1999;13:568-577.
15. Kamel-Reid S, Dick JE. Engraftment of immunedeficient mice with human hematopoietic stem cells. Science. 1988;242:1706-1709.
16. Mager DL, Freeman JD. Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses. J Virol. 1987;61:4060-4066.
17. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92:2322-2333.
18. Berenson RJ, Andrews RG, Bensinger WI, et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest. 1988;81:951-955.
19. Civin CI, Small D. Purification and expansion of human hematopoietic stem/progenitor cells. Ann N Y Acad Sci. 1995;770:91-98.
20. Wolf NS, Kone A, Priestley GV, Bartelmez SH. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp Hematol. 1993;21:614-622.
21. Leemhuis T, Yoder MC, Grigsby S, Aguero B, Eder P, Srour EF. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123. Exp Hematol. 1996;24:1215-1224.
22. Bradford GB, Williams B, Rossi R, Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol. 1997;25:445-453.
23. Bertolini F, Battaglia M, Lanza A, et al. Multilineage long-term engraftment potential of drugresistant hematopoietic progenitors. Blood. 1997;90:3027-3036.
24. Blair A, Hogge DE, Allies LE, Lansdorp PM, Sutherland HJ. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood. 1997;89:3104-3112.
25. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999;94:2548-2554.
26. Ailles LE, Gerhard B, Kawagoe H, Hogge DE. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood. 1999;94:1761-1772.
27. Beeler TJ, Gable K. Activation and inhibition of the sarcoplasmic reticulum Ca2+ channel by the polycationic dyes Hoechst 33342 and Hoechst 33258. J Membr Biol. 1993;135:109-118.
28. Zhang X, Chen J, Davis B, Kiechle F. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo. Arch Pathol Lab Med. 1999;123:921-927.